Modulating receptor function through RAMPs

can they represent drug targets in themselves?

Patrick M. Sexton, David R. Poyner, John Simms, Arthur Christopoulos, Debbie L. Hay

Research output: Contribution to journalArticle

Abstract

G protein-coupled receptors (GPCRs) are successfully exploited as drug targets. As our understanding of how distinct GPCR subtypes can be generated expands, so do possibilities for therapeutic intervention via these receptors. Receptor activity-modifying proteins (RAMPs) are excellent examples of proteins that enhance diversity in. GPCR function. They facilitate the creation of binding pockets, controlling the pharmacology of some GPCRs. Moreover, they have the ability to regulate cell-surface trafficking, internalisation and signalling of GPCRs, creating novel opportunities for drug discovery. RAMPs could be directly targeted by drugs, or advantage could be taken of unique RAMP/GPCR interfaces for generating highly selective ligands.
Original languageEnglish
Pages (from-to)413-419
Number of pages7
JournalDrug Discovery Today
Volume14
Issue number7-8
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Receptor Activity-Modifying Proteins
G-Protein-Coupled Receptors
Pharmaceutical Preparations
Drug Discovery
Pharmacology
Ligands

Keywords

  • G protein-coupled receptors
  • receptors
  • receptor activity-modifying proteins
  • RAMPs
  • highly selective ligands

Cite this

Sexton, Patrick M. ; Poyner, David R. ; Simms, John ; Christopoulos, Arthur ; Hay, Debbie L. / Modulating receptor function through RAMPs : can they represent drug targets in themselves?. In: Drug Discovery Today. 2009 ; Vol. 14, No. 7-8. pp. 413-419.
@article{5536f1cac42a4a75b89d9c8ee8135046,
title = "Modulating receptor function through RAMPs: can they represent drug targets in themselves?",
abstract = "G protein-coupled receptors (GPCRs) are successfully exploited as drug targets. As our understanding of how distinct GPCR subtypes can be generated expands, so do possibilities for therapeutic intervention via these receptors. Receptor activity-modifying proteins (RAMPs) are excellent examples of proteins that enhance diversity in. GPCR function. They facilitate the creation of binding pockets, controlling the pharmacology of some GPCRs. Moreover, they have the ability to regulate cell-surface trafficking, internalisation and signalling of GPCRs, creating novel opportunities for drug discovery. RAMPs could be directly targeted by drugs, or advantage could be taken of unique RAMP/GPCR interfaces for generating highly selective ligands.",
keywords = "G protein-coupled receptors, receptors, receptor activity-modifying proteins, RAMPs, highly selective ligands",
author = "Sexton, {Patrick M.} and Poyner, {David R.} and John Simms and Arthur Christopoulos and Hay, {Debbie L.}",
year = "2009",
month = "4",
doi = "10.1016/j.drudis.2008.12.009",
language = "English",
volume = "14",
pages = "413--419",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier",
number = "7-8",

}

Modulating receptor function through RAMPs : can they represent drug targets in themselves? / Sexton, Patrick M.; Poyner, David R.; Simms, John; Christopoulos, Arthur; Hay, Debbie L.

In: Drug Discovery Today, Vol. 14, No. 7-8, 04.2009, p. 413-419.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulating receptor function through RAMPs

T2 - can they represent drug targets in themselves?

AU - Sexton, Patrick M.

AU - Poyner, David R.

AU - Simms, John

AU - Christopoulos, Arthur

AU - Hay, Debbie L.

PY - 2009/4

Y1 - 2009/4

N2 - G protein-coupled receptors (GPCRs) are successfully exploited as drug targets. As our understanding of how distinct GPCR subtypes can be generated expands, so do possibilities for therapeutic intervention via these receptors. Receptor activity-modifying proteins (RAMPs) are excellent examples of proteins that enhance diversity in. GPCR function. They facilitate the creation of binding pockets, controlling the pharmacology of some GPCRs. Moreover, they have the ability to regulate cell-surface trafficking, internalisation and signalling of GPCRs, creating novel opportunities for drug discovery. RAMPs could be directly targeted by drugs, or advantage could be taken of unique RAMP/GPCR interfaces for generating highly selective ligands.

AB - G protein-coupled receptors (GPCRs) are successfully exploited as drug targets. As our understanding of how distinct GPCR subtypes can be generated expands, so do possibilities for therapeutic intervention via these receptors. Receptor activity-modifying proteins (RAMPs) are excellent examples of proteins that enhance diversity in. GPCR function. They facilitate the creation of binding pockets, controlling the pharmacology of some GPCRs. Moreover, they have the ability to regulate cell-surface trafficking, internalisation and signalling of GPCRs, creating novel opportunities for drug discovery. RAMPs could be directly targeted by drugs, or advantage could be taken of unique RAMP/GPCR interfaces for generating highly selective ligands.

KW - G protein-coupled receptors

KW - receptors

KW - receptor activity-modifying proteins

KW - RAMPs

KW - highly selective ligands

UR - http://www.scopus.com/inward/record.url?scp=62849124664&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2008.12.009

DO - 10.1016/j.drudis.2008.12.009

M3 - Article

VL - 14

SP - 413

EP - 419

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 7-8

ER -